25 oct
|
AstraZeneca
|
Álava
AstraZeneca Rare Disease is seeking a Director to lead general value, access, and pricing strategies for NMOSD, with a strong focus on Neurology indications and lifecycle management. You will shape payer strategies across EU markets and collaborate with cross-functional teams to enable rapid patient access.
The role requires deep HTA/payer expertise, strategic thinking, and the ability to drive evidence generation plans, market access readiness, and local P&R; submissions in a high-visibility
#J-*-Ljbffr
📌 Global Nmosd Access (Álava)
🏢 AstraZeneca
📍 Álava